PBYI FY 2020 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

PBYIPuma Biotechnology, Inc.

$299M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$225M-17.3% YoY

Gross Profit

$186M82.5% margin

Operating Income

-$30M-13.5% margin

Net Income

-$60M-26.7% margin

EPS (Diluted)

$-1.52

Cash Flow

Operating Cash Flow

$800,000

Free Cash Flow

-$19M

Stock-Based Comp.

$37M

Balance Sheet

Total Assets

$244M

Total Liabilities

$250M

Stockholders' Equity

-$6M

Cash & Equivalents

$85M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$225M	$272M	-17.3%
Gross Profit	$186M	$235M	-21.1%
Operating Income	-$30M	-$76M	+59.8%
Net Income	-$60M	-$76M	+20.6%